Evidence map›Paper›PMID 26082778›Full record

ReviewFrontiers in immunology2015

The Content and Size of Hyaluronan in Biological Fluids and Tissues.

Mary K Cowman, Hong-Gee Lee, Kathryn L Schwertfeger, James B McCarthy, Eva A Turley

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Frontiers in immunology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06611631 (Clinical and Radiographic Evaluation of Hyaluronic Acid), which is not on this map. Cited by 172 papers.

0numbers the graph read from it
0cells of the map it votes in
172citing papers in PubMed
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06611631 phase1not yet recruitingnot on this mapstarted 2025, after this paper: background citation

Clinical and Radiographic Evaluation of Hyaluronic Acid (Gengigel Teething) Versus Mineral Trioxide Aggregate( Angelus) as Pulpotomy Agent in Vital Primary Molars: A Randomized Clinical Trial

TypeinterventionalSponsorCairo UniversityRan2025 to 2026Enrolled34ConditionsPulpotomies Primary Teeth, Pulp Disease, DentalArmsHyaluronic acid pulpotomy, mineral trioxide aggregate pulpotomy
3 · Its place in the literature

Who cites it

172 citing papers in PubMed, 326 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. NanoformulatedNanomaterials (Basel, Switzerland) · 2026
    Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Resilient Calvarial Bone Marrow Supports Retinal Repair in Type 2 Diabetes.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review

112 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Mary K CowmanDepartment of Chemical and Biomolecular Engineering, Biomatrix Research Center, New York University Polytechnic School of Engineering , New York, NY , USA.
Hong-Gee LeeDepartment of Chemical and Biomolecular Engineering, Biomatrix Research Center, New York University Polytechnic School of Engineering , New York, NY , USA.
Kathryn L SchwertfegerDepartment of Laboratory Medicine and Pathology, Masonic Comprehensive Cancer Center, University of Minnesota , Minneapolis, MN , USA.
James B McCarthyDepartment of Laboratory Medicine and Pathology, Masonic Comprehensive Cancer Center, University of Minnesota , Minneapolis, MN , USA.
Eva A TurleyDepartment of Oncology, London Health Sciences Center, Schulich School of Medicine, Western University , London, ON , Canada ; Department of Biochemistry, London Health Sciences Center, Schulich School of Medicine, Western University , London, ON , Canada ; Department of Surgery, London Health Sciences Center, Schulich School of Medicine, Western University , London, ON , Canada.
New York University · USUniversity of Minnesota · USWestern University · CA

Funding

Women's CancerP30CA077598 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Douglas Yee · 1998 to 2026
$100.4M
Inflammation in Breast Cancer Initiation and PromotionR01CA132827 · NCI · UNIVERSITY OF MINNESOTA · PI SCHWERTFEGER, KATHRYN L · 2011 to 2015
$1.5M
NCI NIH HHS P30 CA077598NCI NIH HHS R01 CA132827
6 · The paper itself

Abstract

Hyaluronan is a simple repeating disaccharide polymer, synthesized at the cell surface by integral membrane synthases. The repeating sequence is perfectly homogeneous, and is the same in all vertebrate tissues and fluids. The polymer molecular mass is more variable. Most commonly, hyaluronan is synthesized as a high-molecular mass polymer, with an average molecular mass of approximately 1000-8000 kDa. There are a number of studies showing increased hyaluronan content, but reduced average molecular mass with a broader range of sizes present, in tissues or fluids when inflammatory or tissue-remodeling processes occur. In parallel studies, exogenous hyaluronan fragments of low-molecular mass (generally, <200 kDa) have been shown to affect cell behavior through binding to receptor proteins such as CD44 and RHAMM (gene name HMMR), and to signal either directly or indirectly through toll-like receptors. These data suggest that receptor sensitivity to hyaluronan size provides a biosensor of the state of the microenvironment surrounding the cell. Sensitive methods for isolation and characterization of hyaluronan and its fragments have been developed and continue to improve. This review provides an overview of the methods and our current state of knowledge of hyaluronan content and size distribution in biological fluids and tissues.

Indexed as

assayhyaluronanmolecular massmolecular weightquantification

Identifiers

PMID26082778
PMCPMC4451640
OpenAlexW2142011208

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.